Karmelek Nicolas

CRO Karmelek Nicolas buys 1,209 shares as stock trades below 52-week high; fifth open-market purchase in 36 months, but mixed timing on prior purchases.

Karmelek Nicolas, the Chief Risk Officer, purchased over 1,200 shares on open market, marking his fifth such purchase within the past 36 months and representing an 18.6% increase to his stake. The stock currently trades noticeably below its 52-week high, providing context for the timing of this purchase. Examining his previous four purchases at Avidia reveals mixed results: three were followed by stock appreciation, but one recent purchase has declined. The broader picture shows five insiders purchased shares within the same two-week window, indicating multiple executives are deploying capital into the stock despite the company's current financial losses. This cluster activity, combined with the insider's repeat buying pattern, warrants closer examination of whether these purchases reflect contrarian positioning into a company working through losses, or simply routine portfolio allocation.

EVP and Chief Risk Officer Karmelek Nicolas buys shares amid multi-insider accumulation despite unprofitable financials

Karmelek Nicolas, the EVP and Chief Risk Officer at Avidia Bancorp, purchased shares while the company is posting significant losses and the stock is recovering from a pullback below its recent highs. What distinguishes this trade is that it's part of a cluster—five insiders have bought stock within a two-week window—suggesting coordinated conviction rather than an isolated vesting or portfolio rebalancing event. For a C-suite risk executive to be accumulating shares when the company is unprofitable indicates either confidence that losses are temporary and fixable, or alternatively, insider knowledge of stabilizing developments not yet public. The fact that multiple unrelated insiders are buying in the same tight window amplifies the signal: this looks like opportunistic accumulation at depressed valuations rather than routine compensation.

EVP/CRO Karmelek buys 1,090 shares of AVBC at $18.59; stock up 13.5% in 90 days, part of 3-insider cluster in 14 days

Karmelek Nicolas (EVP and CRO) purchased 1,090 shares at $18.59 on 2026-03-02, increasing his holdings by 20.2% to 6,485 shares. This buy comes on the heels of two prior purchases at this same ticker in August 2025, both of which generated positive 90-day returns of 4.5% and 7.1% respectively, indicating a consistent pattern of well-timed entries at AVBC. The current price of $18.69 reflects a 13.5% gain over the past 90 days from the broader market context. Notably, this transaction occurs within a 14-day window where 2 other insiders also bought AVBC shares, forming a cluster purchase pattern that typically signals coordinated conviction among the management team. However, the company faces a headwind: net income is negative at $-907.0K, a fundamental concern that offsets the otherwise constructive insider activity and timing history.

EVP/CRO buys 25,979 shares for $374,620.97 at AVBC; 6 insiders also bought in 14 days amid negative earnings

Karmelek Nicolas, EVP and CRO, acquired 25,979 shares across 2 transactions on 2025-08-05 and 2025-08-06 at prices of $14.35 and $14.44, totaling $374,620.97 at a blended average of $14.42. His post-transaction holdings stand at 21,137 shares. This filing is noteworthy because it is part of a cluster pattern: 6 other insiders also bought within the past 14 days, suggesting coordinated accumulation during a period when the company reported negative net income of $-11,587,000.00. The company is also a recent listing (5 trading days), adding uncertainty to valuation context and making early insider buying behavior a closely watched signal. The concentration of insider purchases near the IPO/listing phase, combined with the loss position, merits investigation into management's conviction and what information may be driving this buying."